Broach Lifecare Hospital Limited (BSE SME)
August 13, 2024 – August 16, 2024
| Price | ₹25 - ₹25 |
| Premium | ₹0 |
|---|---|
| Lot size | 6000 |
| Allotment | Aug 20, 2024 |
| Listing | Aug 21, 2024 |
501, 5th Floor, Corporate House,
above Bharuch Orthopedic Hospital,
R K Casta, Bharuch-392001
Phone: +91 94291 87226
Email: info@maplehospital.in
Website: https://www.maplehospital.in/
Last updated on 16-Aug-2024 17:10:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| HNIs | 762000 | 70104000 | 92 |
| Retail | 762000 | 172458000 | 226.32 |
| Total | 1524000 | 239982000 | 157.47 |
| Total Applications: 45429 | |||
| HNI Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹3.09 | @8% ₹3.53 | @9% ₹3.97 | @10% ₹4.41 | @11% ₹4.85 | @12% ₹5.29 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 6000 | 150000 | 127 |
| HNI | 2 | 12000 | 300000 | 127 |
Broach Lifecare Hospital IPO Reservation
| Investor Category | Shares Offered | No. of Shares |
|---|---|---|
| Retail | 47.4% | 762000 |
| Other | 47.4% | 762000 |
| Market Maker | 5.2% | 84000 |
| Total No. of Shares | 100.0% | 1608000 |
Broach Lifecare Hospital IPO Details
| Issue Size | 1,608,000 shares (aggregating up to ₹4.02 Cr) |
| Fresh Issue | 1,608,000 shares (aggregating up to ₹4.02 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Share holding pre issue | 4,462,380 |
| Share holding post issue | 6,070,380 |
| Market Maker portion | 84,000 shares Aftertrade Broking |
Key Performance Indicator
| KPI | Mar-24 |
|---|---|
| ROE | 12.76% |
| ROCE | 17.09% |
| RONW | 12.75% |
| D/E | - |
| EPS (Diluted) | 1.92 |
| P/E Pre IPO | 15.99 |
| P/E Post IPO | 21.75 |
Company Financials
Broach Lifecare Hospital Limited Financial Information (Restated)
| Period | Mar 2024 |
|---|---|
| Assets | 571.62 |
| Revenue | 260.58 |
| Profit | 69.76 |
| Net Worth | 546.92 |
| Reserves | 100.68 |
| Amount in ₹ Lakhs | |
About Company
Broach Lifecare Hospital Limited, established in 2023, operates a boutique hospital chain under the brand "Maple Hospitals". Specializing in cardiac care, the company provides round-the-clock non-invasive cardiology services and advanced coronary care at its NABH-certified Bharuch facility. Equipped with 25 ultra-luxury beds, cutting-edge diagnostic tools, and life-saving equipment, the hospital caters to patients with heart ailments. With a team of 19 employees, Maple Hospitals is affiliated with numerous insurance providers and has obtained requisite certifications for safety and waste management.
Strength
Specialized Cardiac Care: Offering dedicated 24/7 services and advanced equipment.
Patient-Centric Approach: NABH accreditation and focus on ultra-luxury facilities.
Strong Industry Network: Empanelment with major insurance providers.
Weakness
Limited Operating History: The Company’s recent incorporation and reliance on an existing proprietorship limits historical financial data, making future performance evaluation challenging for investors.
Key Personnel Dependence: The company heavily relies on its doctors and key personnel. Losing or being unable to attract and retain these individuals could significantly impact operations and financial results.
Promoter Concentration: Substantial dependence on the promoters for the company's success. Any loss of their services could adversely affect business and financial performance.